Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

NCT05741476 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy, Peanut

Interventions

DRUG: DBV712
OTHER: Placebo
DRUG: DBV712

Sponsor

DBV Technologies